Here, the authors established protocols for generating CD8+ T cells from human induced pluripotent stem cells (hiPSCs) expressing a melanoma‐specific T cell receptor (TCR) or chimeric antigen receptor (CAR) construct. This evidence concerns the gene CD8A and melanoma.